The impact of COVID-19 on retail and food-to-go channels has challenged many food businesses. Yet challenger brands and start-ups with an agile mindset can use the crisis to their advantage, say a panel of experts.
French clinical-stage microbiome specialist MaaT Pharma has raised €18 million in Series B financing as it looks to continue development of its microbiome-based biotherapeutics pipeline, and expand cancer indications.
Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.